In results from a Phase Ib study, Hernexeos showed a 75 percent response rate and more than half of patients responded for at least six months.

With the FDA approval of its zongertinib in certain non-small cell lung cancer (NSCLC) patients, 175-year-old Boehringer ...

Zongertinib gains FDA approval for advanced NSCLC with HER2 mutations, showcasing promising efficacy and safety in clinical ...

The research suggests common respiratory infections, such as the flu or COVID, are capable of stirring dormant cancer cells ...

Treatment with adagrasib (Krazati) significantly improved progression-free-survival (PFS) in previously treated patients with ...

Potent Impact on Colorectal Liver Metastasis: In an experimental liver metastatic model of colorectal carcinoma (CT26 Luc), Annamycin significantly inhibited metastatic growth and extended survival, ...

A Shropshire charity says it is ready to start clinical trials on a new drug to treat lung cancer. Although the charity ...

What if a computer could read a patient's medical notes and help doctors determine important information for their treatment?

Tumor cells rob other cells' mitochondria to energize their spread. For the first time, scientists discovered such theft from neurons.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Nuvation Bio Inc. (NYSE:NUVB) is one of the penny stocks that will skyrocket. On June 24, the company confirmed the addition ...

A team led by researchers at MUSC Hollings Cancer Center developed an artificial intelligence tool that uses natural language ...